logo

For the Inventor, By the Inventor

Bothell, WA, United States of America

Tomikazu Sasaki

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: University of Washington. Active years: 2010-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomikazu Sasaki. Retrieved from https://idiyas.com/inventor/tomikazu-sasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 20.0


Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Bothell, WA (US) (2010 - 2015)
  • Seattle, WA (US) (2016 - 2019)

Company Filing History:

goldMedal5 out of 2,172 
 
University of Washington
 patents

Years Active: 2010-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 10329258 - CGAS in systemic lupus erythematosus (SLE) (2019-06-25),
2. 9422306 - Artemisinin compounds and synthesis and use thereof (2016-08-23),
3. 9169291 - Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents (2015-10-27),
4. 8048850 - Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use (2011-11-01),
5. 7692030 - Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer (2010-04-06),

Title: Tomikazu Sasaki: Innovator in Therapeutic Strategies

Introduction

Tomikazu Sasaki is a prominent inventor based in Bothell, WA (US). He has made significant contributions to the field of therapeutic strategies, particularly in the treatment of severe debilitating diseases. With a total of 5 patents, his work has garnered attention for its innovative approaches to complex medical conditions.

Latest Patents

One of his latest patents focuses on CGAS in systemic lupus erythematosus (SLE). This invention provides therapeutic strategies for treating severe debilitating diseases associated with IFN-I due to cGAS activation. The invention includes compounds of Formula (I) and outlines pharmaceutical uses thereof. Additionally, it presents methods for treating autoimmune diseases or monogenic disorders by administering an effective amount of a compound of Formula (I). Another notable patent involves artemisinin compounds, detailing their synthesis and use. These compounds can be synthesized using an Ugi synthesis reaction and are applicable in the treatment of cancers, parasitic infections, and yeast infections.

Career Highlights

Tomikazu Sasaki is affiliated with the University of Washington, where he continues to advance his research and innovations. His work has been instrumental in developing new therapeutic strategies that address critical health challenges.

Collaborations

He has collaborated with notable colleagues, including Narendra Pal Singh and Henry C Lai, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tomikazu Sasaki's contributions to the field of therapeutic strategies highlight his role as an influential inventor. His innovative patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…